WAYLAND, Mass.--(BUSINESS WIRE)--Candela Corporation (NASDAQ:CLZR) today announced that it has received registration approval from the Chinese State Food and Drug Administration (SFDA) to market the full line of Vbeam® lasers in the People’s Republic of China.
